Next-generation synthetic trials in hematology with generative artificial intelligence - Nature

Researchers are using AI to create synthetic clinical trial data for blood disorder treatments, potentially speeding up drug development and reducing the need for traditional patient trials. This could help get new hematology medicines to patients faster, though actual clinical validation remains important.